TrialEuropean heart journal2016

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Geeta Gulati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.